2009
DOI: 10.1159/000167864
|View full text |Cite
|
Sign up to set email alerts
|

The Difference in p53 Mutations between Cancers of the Upper and Lower Gastrointestinal Tract

Abstract: Background:p53 gene mutations have been reported in over half of all human cancers and they appear to occur in the early stage of cancer, thus indicating the important role that such mutations may play in the carcinogenesis of the digestive tract. This study investigated the differences in p53 abnormalities between cancers of the upper and lower gastrointestinal tract. Materials and Methods: The DNA of 354 specimens of gastrointestinal cancer (esophagus 85, stomach 112, colon 157) was extracted and then p53 ge… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
28
1
2

Year Published

2010
2010
2016
2016

Publication Types

Select...
7
2

Relationship

4
5

Authors

Journals

citations
Cited by 39 publications
(32 citation statements)
references
References 57 publications
(29 reference statements)
1
28
1
2
Order By: Relevance
“…The major adduct of BaP produces a G-to-T transversion [52], and 40%-50% of p53 gene mutations in Japanese patients with ESCC are predominantly the transversion of G to T [70,71]; these findings also suggest that cigarette smoke might be related to esophageal carcinogenesis. However, Pfeifer et al [35] have noted that it is difficult to identify the unambiguous molecular signature of tobacco carcinogens in the p53 mutational spectrum of esophageal cancer, because the patterns of mutation are extremely heterogeneous.…”
Section: General Mechanisms Of Smoking-induced Carcinogenesismentioning
confidence: 99%
“…The major adduct of BaP produces a G-to-T transversion [52], and 40%-50% of p53 gene mutations in Japanese patients with ESCC are predominantly the transversion of G to T [70,71]; these findings also suggest that cigarette smoke might be related to esophageal carcinogenesis. However, Pfeifer et al [35] have noted that it is difficult to identify the unambiguous molecular signature of tobacco carcinogens in the p53 mutational spectrum of esophageal cancer, because the patterns of mutation are extremely heterogeneous.…”
Section: General Mechanisms Of Smoking-induced Carcinogenesismentioning
confidence: 99%
“…DNA was extracted as described previously (23,24). Briefly, the frozen samples were incubated in a lysis buffer (0.01 mol/L Tris-HCl, pH 8.0; 0.1 mol/L EDTA, pH 8.0; 0.5% SDS) containing proteinase K (100 mg/mL) at 37 C for 2 hours.…”
Section: Dna Preparationmentioning
confidence: 99%
“…PCR direct sequencing of the p53 gene As previously described (23,24), using with genomic DNA extracted from cell lines and tissue samples, a 275-bp fragment containing exon 6, a 439-bp fragment containing exon 7, and a 445-bp fragment containing exons 8 and 9 of the p53 gene were amplified by PCR (Nippon Gene). The PCR primers for the amplification of a 406-bp fragment containing exon 5 of p53 were as follows: exon 5 forward, TGC AGG AGG TGC TTA CAC ATG; exon 5 reverse, TCC ACT CGG ATA AGA TGC TG.…”
Section: Dna Preparationmentioning
confidence: 99%
“…A high frequency of TP53 mutations and p53 protein expression in ESCC has been reported [5,6], and both have been assessed as potential predictive markers of chemotherapy response and prognosis for ESCC [7][8][9][10]. However, the association between p53 expression and clinicopathological findings or prognosis remains controversial.…”
Section: Introductionmentioning
confidence: 99%